PAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Osaka International Cancer Institute today announced that they have formed an alliance to advance clinical development in Japan. The partnership …
( read original story …)


Related Post

Chinese investors’ access to Hong Kong’s IPO marke...
views 89
Hong Kong is one of several global equity bourses ...
Japan Gains Ground on Wasteful Workaholics
views 101
First, the good news: Japan has finally begun to w...
Tokyo election, populist leader could shift Japan ...
views 114
An election for Tokyo's metropolitan assembly on S...
Panel's report to support letting Japan'...
views 95
TOKYO -- A government panel studying a possible ab...
Global shares mixed; Japan benchmark falls on weak...
views 45
ASIA'S DAY: Japan's benchmark Nikkei 225 inched do...
Nikkei falls to more than 1-week low as stronger y...
views 83
TOKYO Feb 2 Japan's Nikkei share average fell on T...
Chris Grayling to Japan: 'Some of our trains ...
views 142
Transport minister urges counterparts from Japan t...
Minimal compliance on quake standard – engin...
views 67
Fewer than 34 multi-storey New Zealand buildings h...
Japan’s smaller airports welcome Southeast A...
views 67
The western Japanese city is known for the Atomic ...
Osaka Still Working On Her Game
views 130
For Naomi Osaka, making her main draw debut in her...